Hedge Fund - Octagon Capital Advisors
Apellis Pharmaceuticals Inc. (APLS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $45,795,780 | 8.86% | 2,094,000 | $27.63 |
| 2 | 2024 - Q4 (2024-12-31) | $95,952,732 | 15.78% | 3,006,980 | $30.07 |
| 3 | 2024 - Q3 (2024-09-30) | $86,721,303 | 13.48% | 3,006,980 | $37.03 |
| 4 | 2024 - Q2 (2024-06-30) | $110,510,557 | 17.36% | 2,880,880 | $45.29 |
| 5 | 2024 - Q1 (2024-03-31) | $164,994,284 | 19.77% | 2,806,980 | $63.75 |
| 6 | 2023 - Q4 (2023-12-31) | $168,025,823 | 26.88% | 2,806,980 | $50.73 |
| 7 | 2023 - Q3 (2023-09-30) | $119,065,200 | 18.29% | 3,130,000 | $43.93 |
| 8 | 2023 - Q2 (2023-06-30) | $238,527,130 | 33.19% | 2,618,300 | $86.28 |
| 9 | 2023 - Q1 (2023-03-31) | $214,370,000 | 30.84% | 3,250,000 | $57.70 |
| 10 | 2022 - Q4 (2022-12-31) | $163,403,600 | 25.44% | 3,160,000 | $53.04 |
| 11 | 2022 - Q3 (2022-09-30) | $170,959,000 | 29.5% | 2,503,059 | $59.17 |
| 12 | 2022 - Q2 (2022-06-30) | $116,806,000 | 31.17% | 2,583,059 | $45.59 |
| 13 | 2022 - Q1 (2022-03-31) | $118,898,000 | 25.7% | 2,340,059 | $44.15 |
| 14 | 2021 - Q4 (2021-12-31) | $95,549,000 | 18.59% | 2,020,911 | $39.37 |
| 15 | 2021 - Q3 (2021-09-30) | $52,601,000 | 12.95% | 1,595,911 | $56.19 |
| 16 | 2021 - Q2 (2021-06-30) | $79,396,000 | 16.44% | 1,256,265 | $51.60 |
| 17 | 2021 - Q1 (2021-03-31) | $23,531,000 | 8.86% | 548,374 | $47.32 |
| 18 | 2020 - Q4 (2020-12-31) | $31,367,000 | 10.87% | 548,374 | $42.30 |
The displayed share prices are average quarterly stock market prices.